openPR Logo
Press release

FlowSense: Affordable Antibiotic Testing to Transform the Honey Industry From Biorex Food Diagnostics

06-05-2024 05:21 PM CET | Food & Beverage

Press release from: Biorex Food Diagnostics

FlowSense Antibiotic Kit with Reader

FlowSense Antibiotic Kit with Reader

Biorex Food Diagnostics announced today, the launch of its cutting-edge FlowSense product line, with the first phase designed specifically for the honey industry. The new FlowSense test products introduce a comprehensive range of antibiotic test panels, providing honey producers with an innovative solution to ensure the purity and quality of their products, while also providing an affordable testing option.

The initial release features a selection of single and multiplex rapid test strips, allowing for the detection of up to 49 antibiotics. This unparalleled rapid capability, not only guarantees exceptional accuracy, but also enables honey producers of all sizes to demonstrate the absence of antibiotics in their products, making them more attractive to discerning consumers.

"We're thrilled to introduce FlowSense to the honey industry," said Dr Morteza Afrasiabi, Managing Director at Biorex Food Diagnostics. "With FlowSense, we aim to revolutionize the way honey producers ensure the integrity of their products. Our innovative technology enables producers to perform antibiotic testing with minimal investment and technical expertise, ultimately enhancing consumer trust and marketability." Nicola Kane, R&D Manager at Biorex Food Diagnostics added "This is just the first phase in the FlowSense range, further panels due for release this year also include mycotoxins and pesticides. This expansion will enable access to high-quality laboratory tests outside conventional laboratory settings".

FlowSense offers a range of benefits for end-users, including minimal initial investment requirements, the elimination of expenses associated with third-party testing, and the ability to conduct tests without prior experience or extensive technical knowledge. The portable reader enhances convenience, allowing for on-the-go testing and seamless integration into existing quality schedules.

Key features of the FlowSense product line include:
• Innovative Multiplex Detection Capability: 3-in-1 and 4-in-1 test strips for efficient and comprehensive testing.
• Straight forward Sample Preparation Process: Streamlined procedures for ease of use.
• Detection of 49 Antibiotic Compounds: Comprehensive coverage to ensure product purity.
• Quick 15-Minute Incubation for Nitrofuran Derivatization: Rapid results without compromising accuracy.
• Compliance with MMPRs Council Directive 96/23/EC: Meeting regulatory standards for honey exportation.

The FlowSense Reader complements the test strips with its 5" touch display and intuitive workflow, providing users with a seamless testing experience. With a storage capacity of more than 1000 records, the reader offers efficient data management for enhanced traceability and quality control.

For honey producers seeking to uphold the highest standards of quality and transparency, FlowSense is the ultimate solution.

For more information about FlowSense and how it can benefit your business, please visit www.biorexfooddiagnostics.com.

Biorex Food Diagnostics
Address:
Unit 9A, The Technology Park,
Antrim, Co. Antrim
United Kingdom
BT41 1QS

Contact Details:
Tel: +44 (0) 2894 330 729
Email: sales@biorexfooddiagnostics.com
Name: Clare Lafferty

Biorex Food Diagnostics was established in 2014, acting as a subsidiary of Fortress Diagnostics (a renowned global IVD provider).

We work with food producers, government and 3rd party laboratories and customs import/export departments to deliver innovative food and feed testing kits and improve food safety worldwide.

In recent years, our customer network has expanded greatly and we now export to 28 countries across 5 continents.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release FlowSense: Affordable Antibiotic Testing to Transform the Honey Industry From Biorex Food Diagnostics here

News-ID: 3527175 • Views:

More Releases for FlowSense

Automatic Oxygen Adjustment Oxygen Flow Therapy System Market Future Business Op …
The Automatic Oxygen Adjustment Oxygen Flow Therapy System market is experiencing robust growth due to increasing adoption of smart oxygen delivery technologies across healthcare settings globally. These systems optimize oxygen flow in real-time, enhancing therapeutic outcomes and patient safety, thus driving significant business growth and industry share. Market Size and Overview : The Global Automatic Oxygen Adjustment Oxygen Flow Therapy System Market size is estimated to be valued at USD 850 million
Intelligent Urinary System Dynamic Detector Unlocks Opportunities in Healthcare …
The Intelligent Urinary System Dynamic Detector market is experiencing significant growth as it redefines urological diagnostics with its cutting-edge technology and innovative approach to urinary health. This press release explores the latest developments and key trends within this rapidly expanding market, which holds the potential to transform patient care and enhance urological health. The Intelligent Urinary System Dynamic Detector Market Analysis 2023 Report provides thorough statistical data on the present and
Cerebrospinal Fluid Management Market Research By Major Industry Firms And Top K …
The Cerebrospinal Fluid Management Market size is expected to reach US$ 2,892.54 million by 2030 from US$ 1,911.37 million in 2022; it is estimated to record a CAGR of 5.3% from 2022 to 2030. Cerebrospinal fluid is a fluid found in the brain and spinal cord that safeguards the brain and spinal cord mechanically and immunologically. Various management devices such as CSF shunts and CSF drainage systems are used to manage
Hydrocephalus Shunt Market Comprehensive Analysis Of Factors That Drive And Rest …
According to a new report published by Allied Market Research, titled, "Hydrocephalus Shunt Market: Global Opportunity Analysis and Industry Forecast 2020-2027" The global hydrocephalus shunts market size was valued at $291.00 million in 2019, and is projected to reach $322.01 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Growth in number of hydrocephalic patients across the globe majorly drives growth of the hydrocephalus shunts market. For